Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases

NCT06252454 is registered in ClinicalTrials.gov with University Hospital Hradec Kralove as lead sponsor.

NCT NCT06252454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06252454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases
Lead sponsor
University Hospital Hradec Kralove
Phase
Phase 2/3
Overall status
Unknown status
Start date
February 27, 2024
Completion date
December 31, 2025
Enrollment
102 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyspnea